Parkinson's

   < back>
 

Promoting PP2A activity is a viable disease-modifying therapeutic strategy for α-synucleinopathies such as Parkinsonís Disease. http://www.ncbi.nlm.nih.gov/pubmed/21562258

 

Neuroprotective and anti-inflammatory properties of a coffee component in the MPTP model of Parkinson's Disease. http://www.ncbi.nlm.nih.gov/pubmed/23296837

 

Phosphoprotein phosphatase 2A catalyzes the dephosphorylation of pSer129 alpha-synuclein. http://www.researchgate.net/publication/266156086_Phosphoprotein_phosphatase_2A_
catalyzes_the_dephosphorylation_of_pSer129_alpha-synuclein


   < back>